Director, Bioanalysis
Abdera Therapeutics
South San Francisco, CA, USA
USD 165k-215k / year
Posted on Apr 21, 2025
Who we are At Abdera Therapeutics, we are on a mission to revolutionize cancer treatment. Leveraging our proprietary ROVEr™ platform, we engineer precision radiotherapeutics that finely tune radioisotope delivery to maximize therapeutic effects while sparing healthy tissue. Our innovative approach holds the potential to transform the treatment of a broad range of solid tumors. Abdera’s lead program, ABD-147, is a next-generation precision radiopharmaceutical biologic therapy in Phase 1 clinical development and is designed to deliver Actinium-225 (225Ac) to solid tumors expressing delta-like ligand 3 (DLL3) for the treatment of small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC). Our company, technology, and team are purpose-built to attack cancer head-on. Led by a dynamic team of scientists and industry veterans with extensive experience in oncology, radiopharmaceuticals, and biologics, we are united by a shared passion for cutting-edge science and a relentless pursuit of optimized therapies for people living with cancer. What we look for At Abdera Therapeutics, we are looking for curious and committed individuals who are ready for the opportunity to transform the way people living with cancer can be treated. We are devoted to advancing novel treatment options that offer new hope to families facing devastating diagnoses. We are in search of team members who work collaboratively with a diverse group of colleagues, respectfully engaging one another while collectively and inclusively tackling any challenges we may face. We are building an exciting and fast paced company passionate about discovering and developing tomorrow’s most innovative cancer therapies. Salary range
- Vancouver
- 165k
- 205k Salary range
- SF Bay area 175k
- 215k